140 related articles for article (PubMed ID: 2898112)
1. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.
Nagatsu T; Yoshida M
Neurosci Lett; 1988 Apr; 87(1-2):178-82. PubMed ID: 2898112
[TBL] [Abstract][Full Text] [Related]
2. Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues.
Yoshida M; Ogawa M; Suzuki K; Nagatsu T
Adv Neurol; 1993; 60():207-11. PubMed ID: 8093578
[TBL] [Abstract][Full Text] [Related]
3. Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine in the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats.
Lorenc-Koci E; Smiałowska M; Antkiewicz-Michaluk L; Gołembiowska K; Bajkowska M; Wolfarth S
Neuroscience; 2000; 95(4):1049-59. PubMed ID: 10682712
[TBL] [Abstract][Full Text] [Related]
4. Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes.
Yoshida M; Niwa T; Nagatsu T
Neurosci Lett; 1990 Oct; 119(1):109-13. PubMed ID: 1982957
[TBL] [Abstract][Full Text] [Related]
5. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.
Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J
Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584
[TBL] [Abstract][Full Text] [Related]
6. Migration of tetrahydroisoquinoline, a possible parkinsonian neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry.
Niwa T; Takeda N; Tatematsu A; Matsuura S; Yoshida M; Nagatsu T
J Chromatogr; 1988 Oct; 452():85-91. PubMed ID: 3149649
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.
Ishiwata K; Koyanagi Y; Abe K; Kawamura K; Taguchi K; Saitoh T; Toda J; Senda M; Sano T
J Neurochem; 2001 Nov; 79(4):868-76. PubMed ID: 11723179
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
Brain Res Bull; 2001 Sep; 56(1):55-60. PubMed ID: 11604249
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydroisoquinoline lacks dopaminergic nigrostriatal neurotoxicity in mice.
Perry TL; Jones K; Hansen S
Neurosci Lett; 1988 Feb; 85(1):101-4. PubMed ID: 3362404
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydrobiopterin in striatum: localization in dopamine nerve terminals and role in catecholamine synthesis.
Levine RA; Miller LP; Lovenberg W
Science; 1981 Nov; 214(4523):919-21. PubMed ID: 6117945
[TBL] [Abstract][Full Text] [Related]
11. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.
Naoi M; Maruyama W; Dostert P; Hashizume Y; Nakahara D; Takahashi T; Ota M
Brain Res; 1996 Feb; 709(2):285-95. PubMed ID: 8833765
[TBL] [Abstract][Full Text] [Related]
12. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
Brain Res; 2001 Jul; 907(1-2):134-8. PubMed ID: 11430895
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain.
Antkiewicz-Michaluk L; Romañska I; Papla I; Michaluk J; Bakalarz M; Vetulani J; Krygowska-Wajs A; Szczudlik A
Neuroscience; 2000; 96(1):59-64. PubMed ID: 10683410
[TBL] [Abstract][Full Text] [Related]
15. 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets.
Perry TL; Jones K; Hansen S; Wall RA
Neurosci Lett; 1987 Mar; 75(1):65-70. PubMed ID: 3106859
[TBL] [Abstract][Full Text] [Related]
16. Effect of tetrahydroisoquinoline (TIQ), one of endogenous substances inducing parkinsonism, on isolated rat vas deferens.
Koike K; Takayanagi I; Wani S; Yanagita T; Ohta S; Hirobe M
Gen Pharmacol; 1989; 20(2):259-60. PubMed ID: 2714622
[TBL] [Abstract][Full Text] [Related]
17. Effect of intranigral Mn2+ on striatal and nigral synthesis and levels of dopamine and cofactor.
Daniels AJ; Abarca J
Neurotoxicol Teratol; 1991; 13(5):483-7. PubMed ID: 1684634
[TBL] [Abstract][Full Text] [Related]
18. [Tetrahydroisoquinoline and parkinsonism].
Yoshida M
Rinsho Shinkeigaku; 1989 Dec; 29(12):1501-3. PubMed ID: 2630145
[TBL] [Abstract][Full Text] [Related]
19. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
Hadjiconstantinou M; Mariani AP; Neff NH
Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
[TBL] [Abstract][Full Text] [Related]
20. Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.
Thiruchelvam M; McCormack A; Richfield EK; Baggs RB; Tank AW; Di Monte DA; Cory-Slechta DA
Eur J Neurosci; 2003 Aug; 18(3):589-600. PubMed ID: 12911755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]